Abstract
The article presents the rationale for the development of a set of measures that contribute to the improvement of the risk management procedure during the input control of raw materials and materials entering the pharmaceutical enterprise. The main methods and features of risk management during the input control of raw materials and materials entering the pharmaceutical enterprise are considered. The results of the risk analysis at the entrance control at the pharmaceutical enterprise are presented, the ranking of the identified risks according to the degree and probability of occurrence is carried out. Recommendations are formulated to improve the risk management process during the input control of raw materials used in the production of medicines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
